Alembic Pharma gets USFDA nod for bipolar disorder treatment drug

The approved product is therapeutically equivalent to the reference listed drug product Saphris Sublingual tablets of Allergan Sales, LLC.

from Moneycontrol Latest News https://ift.tt/2W5LTfW